how effective is tirzepatide for weight loss vs. Semaglutide: What's the Difference? Tirzepatide causes more weight loss

Originally developed to treat type 2 diabetes, semaglutide demonstrated such significant weight loss effects in clinical trials that it earned FDA approval specifically for chronic weight management under the brand name Wegovy

& Rosen, N

Among people who took a GLP-1 in the past but stopped, 22% say injections were the main reason they discontinued treatment, and 30% say injections were one of the reasons they stopped

The Truth About GLP-1 Weight Loss Medications GLP-1 receptor agonists like Semaglutide and Tirzepatide were originally designed to help manage Type 2 diabetes , not weight loss

Today, GLP standards are integral to maintaining high-quality and trustworthy data in the scientific community